Figure 13.
Multitargeting compounds incorporating the kinase inhibitory fragment from erlotinib and sulphonamide CAIs of type 36 and compounds 37 and 38 targeting CAs, COX-2, and 15-LOX.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.